These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1142 related items for PubMed ID: 6151891

  • 21. Treatment of phaeochromocytoma and of clonidine withdrawal hypertension with labetalol.
    Rosei EA, Brown JJ, Lever AF, Robertson AS, Robertson JI, Trust PM.
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):809-15. PubMed ID: 990158
    [Abstract] [Full Text] [Related]

  • 22. Combined receptor intervention and myocardial infarction.
    Chamberlain DA, Vincent R.
    Drugs; 1984 Aug; 28 Suppl 2():88-108. PubMed ID: 6151893
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Labetalol compared with prindolol plus hydraliazine in the treatment of hypertension: a double-blind cross-over study.
    Barnett AJ, Kalowski S, Guest C.
    Med J Aust; 1978 Jan 28; 1(2):105-9. PubMed ID: 349319
    [Abstract] [Full Text] [Related]

  • 27. Central and peripheral blockade of the sympathetic nervous system.
    Weber MA, Drayer JI.
    Am J Med; 1984 Oct 05; 77(4A):110-8. PubMed ID: 6148889
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The combined alpha- and beta-adrenergic blocker labetalol and propranolol in the treatment of high blood pressure: similarities and differences.
    Weber MA, Drayer JI, Kaufman CA.
    J Clin Pharmacol; 1984 Oct 05; 24(2-3):103-12. PubMed ID: 6143765
    [Abstract] [Full Text] [Related]

  • 32. Sympathetic nervous activity and the pressor effect of noradrenaline under chronic alpha-beta-adrenoceptor blockade with labetalol in hypertension.
    Zschiedrich H, Neurohr W, Lüth JB, Philipp T, Distler A.
    Klin Wochenschr; 1983 Jul 01; 61(13):661-7. PubMed ID: 6310204
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Oral labetalol in the management of the sympathetic overactivity of severe tetanus.
    Hanna W, Grell GA.
    South Med J; 1980 May 01; 73(5):653-4. PubMed ID: 6103586
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Some haemodynamic effects of compound AH 5158 compared with propranolol, propranolol plus hydrallazine, and diazoxide: the use of AH 5158 in the treatment of hypertension.
    Prichard BN, Thompson FO, Boakes AJ, Joekes AM.
    Clin Sci Mol Med Suppl; 1975 Jun 01; 2():97s-100s. PubMed ID: 802650
    [Abstract] [Full Text] [Related]

  • 40. Labetolol--combined alpha and beta blockade for hypertension.
    Raftery EB.
    Scott Med J; 1978 Oct 01; 23(4):279-80. PubMed ID: 31683
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 58.